Blood Screening Market Size By Resin, By Product, By Application, Industry Analysis Report, Regional Outlook Forecast 2028

Market Overview:

The global blood screening market size is projected to reach USD 4.09 billion by the end of 2026. The increasing awareness regarding blood disorders will lead to a wider adoption across the world. According to a report published by Fortune Business Insights, titled “Blood Screening Market Size, Share & Industry Analysis, By Product Type (Instruments, and Reagents & Kits), By Technology (Molecular Tests, and Serology Tests), By End User (Independent Clinical Laboratories, Hospital-based Laboratories, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 2.31 billion in 2018 and will exhibit a CAGR of 7.4% during the forecast period, 2019-2026.

Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-screening-market-102552

North America to Emerge Dominant; Increasing Investments by Major Companies Will Aid Market Growth

The report analyses the ongoing blood screening market trends across North America, Latin America, Asia Pacific, and the Middle East and Africa. Among these regions, the market in North America currently dominates the global market accounting to the massive adoption of blood screening procedures by people across the country. The increasing awareness regarding the adverse effects of use of contaminated blood has played a major part towards the rapid adoption of this procedure. As of 2018, the market in North America was worth USD 967.0 million and this value is projected to increase further in the coming years.

Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/blood-screening-market-102552

A few of the leading companies that are operating in the global blood screening market include:

Bio-Rad Laboratories, Inc.
Hoffmann-La Roche
Ortho Clinical Diagnostics
BD
DiaSorin S.p.A.
Thermo Fisher Scientific Inc.
Abbott
QUOTIENT
Other Players

Industry Developments:

April 2019: Bio-Rad Laboratories, Inc. announced that it has received approval from the U.S Food Drug and Administration (FDA) for its IH-500 system.

https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998
https://www.fortunebusinessinsights.com/u-s-orthodontics-market-104039
https://www.fortunebusinessinsights.com/dental-market-106251
https://www.fortunebusinessinsights.com/industry-reports/surgical-robots-market-100948
https://www.fortunebusinessinsights.com/wound-care-market-103268
https://www.fortunebusinessinsights.com/industry-reports/next-generation-sequencing-ngs-market-101000

NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

LinkedIn: https://www.linkedin.com/company/fortune-business-insights